Treatment of infantile hemangioma with intense pulsed-light: A case report
DOI:
https://doi.org/10.66344/jpad.24.3.2014.238Keywords:
Infantile hemangioma, intense pulsed-light.Abstract
A five-month-old boy with skin phototype IV was successfully treated for a large infantile hemangioma on his left antecubital fossa with three intense pulsed-light treatments at 4-week interval. The lesion regressed approximately 90% without any side effects leading us to say that intense pulsed-light is a safe and effective modality for treatment of infantile hemangioma in Asian patients.ÂReferences
Caucanas M, Paquet P, Henry F et al. Intense pulsed-light therapy for proliferative haemangiomas of infancy. Case Rep Dermatol Med. 2011;2011:253607. doi: 10.1155/2011/253607. Epub 2011 Dec 27.
Li DN, Gold MH, Sun ZS et al. Treatment of infantile hemangioma with optimal pulse technology. J Cosmet Laser Ther. 2010;12:145-50.
Paquet P, Caucanas M, Piérard-Franchimont C et al. Intense Pulsed-Light in Infantile Hemangiomas. Open Access J Sci Technol. 2014;2:1-6.
Schiestl C, Neuhaus K, Zoller S et al. Efficacy and safety of propranolol as ï¬rst-line treatment for infantile hemangiomas. Eur J Pediatr. 2011;170:493-501.
Pavlakovic H, Kietz S, Lauerer P et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics. 2010;126:1589-93.
Goldberg DJ. Current trends in intense pulsed light. J Clin Aesthet Dermatol. 2012;5:45-53.
Chapas AM, Geronemus RG. Our approach to pediatric dermatologic laser surgery. Lasers Surg Med. 2005;37:255-63.
Tanner JL, Dechert MP, Frieden IJ. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics. 1998;101:446-52.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.